The researchers first identified 69,228 patients with type 2 diabetes and then analyzed the risk of adult-onset seizures among 18,243 adult patients aged 18 or older who were newly prescribed semaglutide, other glucose-lowering agents, or SGLT2 inhibitors (antidiabetic drugs)
This process allows for custom concentrations, different delivery methods, and significantly lower costs compared to brand-name products
10.1177/0333102417691762 76 WidenmaierS
The compounds presented on this site are research reagents These products are sold exclusively to qualified researchers and research institutions for laboratory use
A brief description of this section is listed in Table 2
Semaglutide operates by slowing gastric emptying and signaling fullness to the brain, thereby reducing food intake